-+ 0.00%
-+ 0.00%
-+ 0.00%

Changes in Hong Kong stocks | Yeju Healthcare (06929) rose more than 6% and completed the acquisition of all shares of Italian distributor MC Health to accelerate expansion of global direct sales network

Zhitongcaijing·11/16/2026 06:33:03
Listen to the news

The Zhitong Finance App learned that Yeju Healthcare (06929) rose more than 6%. As of press release, it had risen 6.39% to HK$3.91, with a turnover of HK$935,900.

According to the news, Yeju Medical announced that the company completed the acquisition (transaction) of 100% of the shares (transaction) of Italian distributor McHealth S.r.l. (MC Health) on October 15, 2026. The Group's acquisition shifts the local business to a direct sales model. In addition to deepening customer relationships and improving market responsiveness, it can also tap the growth potential of its leading industry's coronary product portfolio. Once the acquisition is completed, the Group can immediately launch direct sales business through MC Health covering cardiac catheterization centers in Italy.

The announcement stated that since the company was listed in Hong Kong in 2022, it has been working to accelerate the expansion of its global direct sales network. Among them, the Group successively acquired dealers in Indonesia and Taiwan in 2023 and 2025, injecting growth momentum into the Asia-Pacific region, marking an important milestone in the direct sales transformation strategy. With the addition of the Italian market to the direct sales network, along with direct sales teams established in the Netherlands, Belgium and Luxembourg earlier this year, the Group will not only further consolidate its European business footprint, but will also lay a solid foundation for long-term sustainable development through 16 direct sales markets around the world.